Press Releases

Leica Biosystems and CellCarta Expand Collaborative Companion Diagnostic Development Model to Accelerate Commercialization Globally

CellCarta and Leica Biosystems have announced a strategic partnership to bring a proven companion diagnostic (CDx) joint development model from China to biopharma sponsors globally.

Kivo Expands Life Sciences Leadership Team with Appointment of Former Veeva Executive Chris Xistris

Kivo, the unified document and process management system for life sciences teams, announced today that Chris Xistris has joined the company as Vice President of Services.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

Life Sciences Industry Veteran Appointed to Lead Global Commercial Organization

VoxCell BioInnovation and adMare BioInnovations Partner to Advance Novel Antibody Therapies in a Human-Relevant Vascularized Tissue Platform

Kivo Launches Headless GxP to Power Compliant Agentic AI in Drug Development

New open architecture connects AI agents, regulated workflows, and human-authenticated action to Kivo’s GxP-compliant platform.

Yourgene Health Launches Insight DPYD Assay

Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients

Atrandi Biosciences Expands Leadership Team to Accelerate Global Adoption of Capsule-Based Single-Cell Technology

Atrandi announced the appointments of Sam Ropp as Chief Commercial Officer and Susan Tousi as Chairman of the Board. These additions strengthen Atrandi’s leadership team as the company accelerates global adoption of its single-cell multiomic SPC technology.

NGI Becomes First Certified Core Lab and Service Provider for Epigenica’s EpiFinder™ Platforms

Epigenica AB has announced an agreement with the National Genomics Infrastructure, one of the largest technical platforms at SciLifeLab.

Medix Biochemica Announces $5 Million Investment to Expand Recombinant Antigen Capabilities

Medix Biochemica has announced a Board-approved $5 million investment to expand its recombinant antigen and cell culture technology capabilities across its Espoo, Finland and St. Louis, Missouri facilities.

Signant Health Acquires Ametris to Create an End-to-End eCOA and Digital Outcome Measures Platform

Signant Health, the evidence generation company, today announced its acquisition of Ametris (formerly ActiGraph), a global digital health solutions provider.

eClinical Solutions and Hobson & Company Quantify Financial and Operational Value of a Clinical Data Intelligence Platform for Clinical Trials

Bringing price transparency to clinical trial technology investment and return, company unveils ROI calculator for pharmaceutical companies and CROs

NunaBio secures £6.5 million to scale next-generation DNA platform and advance infrastructure for synthetic biology

Neuland secures development collaboration with LIR Life Sciences for transdermal GLP-1

Symeres appoints Henning Steinhagen as CEO to drive next phase of strategic growth 

Hongene Demonstrates Advanced Oligonucleotide CDMO Capabilities Through Support of SiranBio’s Dual-Target siRNA Program

START Research Expands Clinical Leadership with Appointment of Dr. Neel Belani as Clinical Investigator at START New Jersey

Strengthening its clinical research capabilities in one of the nation’s most densely populated and high-opportunity oncology markets

AddParts bolsters pharmaceutical manufacturing resilience with funding to support virtual storeroom innovations

Axithra Appoints Lars Kongsbak as CEO to Lead Next Phase of Growth and Series A Financing

Axithra today announced the appointment of Lars Kongsbak as Chief Executive Officer.

iProcess Global Research launches AxisOne: the R&D operating system for the world

iProcess Global Research Inc. today announced the launch of AxisOne, an AI-powered platform the company calls the R&D operating system for the world.

Leinco Technologies and CellCarta Collaborate to Advance Proteomics Solutions and Applications for Drug Development

Leinco Technologies and CellCarta are pleased to announce a strategic collaboration aimed at advancing proteomics solutions that will benefit the development of immuno-oncology and other targeted therapeutic modalities.